Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 6 of 6 for “"DOTATATE"”.

  1. Gallium-68 DOTATATE PET/CT in Neuroendocrine Tumors

    The general metadata -- e.g., title, author, abstract, subject headings, etc. -- is publicly available, but access to the submitted files is restricted to UT Southwestern campus access and/or authorized UT Southwestern users.

    utswmed Repository record for Gallium-68 DOTATATE PET/CT in Neuroendocrine Tumors (opens in a new tab)

  2. Atherosclerotic inflammation imaging using somatostatin receptor-2 positron emission tomography

    … is that vascular SST2 PET imaging using 68Ga-DOTATATE might offer a more accurate marker of macrophage inflammation than 18F-FDG, with superior coronary imaging and therefore better power to discriminate high-risk vs. low-risk atherosclerotic lesions. Comprehensive molecular, histological and …

    cambridge Repository record for Atherosclerotic inflammation imaging using somatostatin receptor-2 positron emission tomography (opens in a new tab)

  3. Imaging Post-Infarct Myocardial Inflammation with ⁶⁸Ga-DOTATATE PET/MRI and insights into COVID-19 associated myocardial injury

    … to adverse cardiac remodelling. <sup>68</sup>Ga-DOTATATE is a PET radiotracer with high affinity for somatostatin receptor subtype 2 (SST2), which has been shown to be up-regulated in pro-inflammatory macrophages. Aims: To investigate the role of hybrid <sup>68</sup>Ga-DOTATATE PET/MRI for …

    cambridge Repository record for Imaging Post-Infarct Myocardial Inflammation with ⁶⁸Ga-DOTATATE PET/MRI and insights into COVID-19 associated myocardial injury (opens in a new tab)

  4. Targeted radiotherapy in metastatic neuroendocrine tumours: clinical and experimental studies

    … Peptide receptor radiotherapy (PRRT) with 177Lu-DOTATATE targets somatostatin receptors, which are overexpressed on NET cells. PRRT results in symptom relief and often tumour control of NETs, but rarely cure. Tumour response is variable and renal and haematological toxicity are dose-limiting side …

    goteborg Repository record for Targeted radiotherapy in metastatic neuroendocrine tumours: clinical and experimental studies (opens in a new tab)